132 related articles for article (PubMed ID: 25680332)
21. Post-transplantation lymphoproliferative disorder in heart and kidney transplant patients: a single-center experience.
Wasson S; Zafar MN; Best J; Reddy HK
J Cardiovasc Pharmacol Ther; 2006 Mar; 11(1):77-83. PubMed ID: 16703222
[TBL] [Abstract][Full Text] [Related]
22. FDG PET/CT Findings of the Recurrent Posttransplantation Lymphoproliferative Disorder in a Pediatric Liver Transplant Recipient With Right Leg Pain as the Only Complaint.
Bai X; Yang H; Zhuang H
Clin Nucl Med; 2015 Oct; 40(10):832-4. PubMed ID: 26098286
[TBL] [Abstract][Full Text] [Related]
23. Clinical and Radiographic Characteristics of Sinonasal Posttransplant Lymphoproliferative Disorder and Invasive Fungal Sinusitis.
Parasher AK; Lerner DK; Glicksman JT; Nabavizadeh SA; Palmer JN; Adappa ND
ORL J Otorhinolaryngol Relat Spec; 2019; 81(5-6):294-303. PubMed ID: 31600756
[TBL] [Abstract][Full Text] [Related]
24. Primary central nervous system posttransplantation lymphoproliferative disorder after heart and lung transplantation.
Gifford G; Fay K; Jabbour A; Ma DD
Intern Med J; 2015 May; 45(5):583-6. PubMed ID: 25955465
[TBL] [Abstract][Full Text] [Related]
25. Recurrent posttransplant lymphoproliferative disorder involving the larynx and trachea: case report and review of the literature.
Banks CA; Meier JD; Stallworth CR; White DR
Ann Otol Rhinol Laryngol; 2012 May; 121(5):291-5. PubMed ID: 22724273
[TBL] [Abstract][Full Text] [Related]
26. Posttransplant Lymphoproliferative Disorders Presenting as an External Nasal Deformity: A Case Report.
Yuan J; Yan Z; Liu J; Wang N
Ear Nose Throat J; 2021 Sep; 100(5_suppl):614S-617S. PubMed ID: 31910671
[TBL] [Abstract][Full Text] [Related]
27. Posttransplant lymphoproliferative disorder of the lung in a renal transplant recipient treated successfully with surgery.
Foroncewicz B; Mucha K; Usiekniewicz J; Chmura A; Kryst P; SoĊdacki D; Paczek L
Transplant Proc; 2006; 38(1):173-6. PubMed ID: 16504695
[TBL] [Abstract][Full Text] [Related]
28. Post-transplant lymphoproliferative disorders.
Patel PR
Clin Oncol (R Coll Radiol); 1999; 11(2):118-22. PubMed ID: 10378638
[TBL] [Abstract][Full Text] [Related]
29. Cardiac allograft involvement by post-transplantation lymphoproliferative disorder.
Nelson KH; Chatzizisis YS; Steigner ML; Mitchell RN; Blankstein R; Givertz MM
J Am Coll Cardiol; 2013 Sep; 62(10):937. PubMed ID: 23850919
[No Abstract] [Full Text] [Related]
30. Abdominal involvement in pediatric heart and lung transplant recipients with posttransplant lymphoproliferative disease increases the risk of mortality.
Tai CC; Curtis JL; Szmuszkovicz JR; Horn MV; Ford HR; Woo MS; Wang KS
J Pediatr Surg; 2008 Dec; 43(12):2174-7. PubMed ID: 19040929
[TBL] [Abstract][Full Text] [Related]
31. Ileocolic and Jejunal Intussusceptions Requiring Surgical Intervention in a Pediatric Patient with Posttransplant Lymphoproliferative Disorder.
Maizlin I; Klima DA; Beierle EA
Am Surg; 2016 Sep; 82(9):792-3. PubMed ID: 27670566
[TBL] [Abstract][Full Text] [Related]
32. Surgical management of perforated gastrointestinal posttransplantation lymphoproliferative disorder after heart transplantation.
Osawa H; Uemura M; Nishimura J; Hata T; Takemasa I; Mizushima T; Yamamoto H; Doki Y; Mori M
Int Surg; 2015 Feb; 100(2):358-64. PubMed ID: 25692442
[TBL] [Abstract][Full Text] [Related]
33. Thoracic presentations of posttransplant lymphoproliferative disorders.
Halkos ME; Miller JI; Mann KP; Miller DL; Gal AA
Chest; 2004 Dec; 126(6):2013-20. PubMed ID: 15596707
[TBL] [Abstract][Full Text] [Related]
34. Massive pseudolymphomatous pericardial effusion in the posttransplant setting mimicking posttransplant lymphoproliferative disease.
Hudnall SD; Melez K; Galindo A; Bryson Y
Transplantation; 1996 Jun; 61(12):1776-8. PubMed ID: 8685960
[TBL] [Abstract][Full Text] [Related]
35. Otolaryngological manifestations of posttransplant lymphoproliferative disorder in pediatric thoracic transplant patients.
Herrmann BW; Sweet SC; Hayashi RJ; Canter CE; White FV; Lieu JE
Int J Pediatr Otorhinolaryngol; 2006 Feb; 70(2):303-10. PubMed ID: 16125255
[TBL] [Abstract][Full Text] [Related]
36. Posttransplantation lymphoproliferative disorder in pediatric recipients of solid organ transplants: timing and location of disease.
Wilde GE; Moore DJ; Bellah RD
AJR Am J Roentgenol; 2005 Nov; 185(5):1335-41. PubMed ID: 16247159
[TBL] [Abstract][Full Text] [Related]
37. Tumor origin and CD20 expression in posttransplant lymphoproliferative disorder occurring in solid organ transplant recipients: implications for immune-based therapy.
Gulley ML; Swinnen LJ; Plaisance KT; Schnell C; Grogan TM; Schneider BG;
Transplantation; 2003 Sep; 76(6):959-64. PubMed ID: 14508361
[TBL] [Abstract][Full Text] [Related]
38. The value of 18F-FDG PET in pediatric patients with post-transplant lymphoproliferative disorder at initial diagnosis.
Vali R; Punnett A; Bajno L; Moineddin R; Shammas A
Pediatr Transplant; 2015 Dec; 19(8):932-9. PubMed ID: 26515450
[TBL] [Abstract][Full Text] [Related]
39. Posttransplant lymphoproliferative disorder: intrathoracic manifestations.
Dodd GD; Ledesma-Medina J; Baron RL; Fuhrman CR
Radiology; 1992 Jul; 184(1):65-9. PubMed ID: 1609104
[TBL] [Abstract][Full Text] [Related]
40. A clinically aggressive, polymorphic, polyclonal posttransplantation lymphoproliferative disorder.
Dunphy CH; Batanian JR
Cancer Genet Cytogenet; 1998 Oct; 106(1):49-53. PubMed ID: 9772909
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
